Anheuser-Busch InBev (InBev) will unload its Australian Carlton & United Breweries unit to Japanese beer giant Asahi in a deal worth US$11.3 billion. The deal was announced on Friday, July 19, the day AB InBev was originally scheduled to list its Asia business on the Hong Kong Stock Exchange in an IPO that could have raised as much as US$9.8 billion. The IP was cancelled due to market conditions, according to the company.
The brewer has struggled particularly in the US, where its flagship Budweiser and Bud Light brands have bled market share to rivals. In response, InBev has snapped up craft brewers, launched limited-editions of Bud and new flavors for Bud Light, and put more marketing behind its low-carb brew Michelob Ultra, but the moves haven’t fixed the problem according to Beer Marketer’s Insights, the Wall Street Journal reported.
Under the terms of the deal, which is expected to close by the first quarter of 2020, InBev will grant Asahi the rights to commercialize the portfolio of InBev’s global and international brands in Australia.
Full Content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan